Product Description
Product Name: Erloceva Tablets 150mg
Product Form: Tablets
Pack Size: 30 tablets
Manufactured By: Bruck Pharma,
Used For
-
If the active ingredient is erlotinib, it is used for certain types of non-small cell lung cancer and other approved cancer indications depending on tumour characteristics.
-
Treatment suitability is determined by an oncology specialist.
Side Effects
-
Acne-like skin rash, diarrhoea, reduced appetite, and fatigue may occur.
-
Serious risks include lung inflammation, liver injury, and gastrointestinal complications.
Key Ingredients & Benefits
-
Active Ingredient: Erlotinib 150mg, if confirmed.
-
Inhibits epidermal growth factor receptor (EGFR) signalling in eligible cancers.
How To Use
-
Use only under oncology supervision and according to the official product instructions.
-
Food timing and interactions must be checked against the specific product leaflet.
Precautions & Warnings
-
Requires monitoring for skin, lung, liver, and gastrointestinal adverse effects.
-
Report severe breathing problems or abdominal pain urgently.
Storage Instructions
-
Follow the manufacturer's storage instructions.
Safety Information
-
Prescription anticancer medicine.
-
Confirm the ingredient and strength before publishing.
-
Keep out of reach of children and do not use after expiry.